期刊
CRITICAL CARE CLINICS
卷 38, 期 2, 页码 393-412出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ccc.2021.11.007
关键词
Autoimmune encephalitis; Diagnosis; Treatment; Critical care; Autoantibody; Paraneoplastic; NMDA receptor encephalitis; Autoimmune encephalitis; Diagnosis; Treatment; Critical care; Autoantibody; Paraneoplastic; NMDA receptor encephalitis
Autoimmune encephalitis is a rapidly progressive neurological condition with significant morbidity and mortality. Its pathogenesis is diverse and noninfectious, immune-mediated causes have gained increasing recognition. Autoantibody-mediated encephalitis has become a focus of research.
Autoimmune encephalitis is a rapidly progressive neurologic condition with significant morbidity and mortality, characterized by altered mental status that can often progress to autonomic instability and refractory seizures requiring care in the intensive care unit.1 While infectious, especially viral, encephalitis is generally more common,2 the last decade has seen increasing recognition of noninfectious, immune-mediated causes of encephalitis. The pathogenic mechanisms of immune-mediated encephalitis are diverse, ranging from encephalitis mediated by the innate immune system such as in febrile infection-related epilepsy syndromes (FIRES, reviewed elsewhere in this issue), to encephalitis dominated by T cell-mediated immunity triggered by onconeural antigens (typified by anti-Hu associated encephalitis), to encephalitis whose pathogenesis is dominated by autoantibody (autoAb)-mediated effects. Our discussion of autoimmune encephalitis (AE) will focus on autoAb-mediated encephalitis whereby
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据